HLT vs STRO · P/E 51, rev $11.17B vs rev $62.0M
Hilton Worldwide Holdings Inc (HLT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Hilton Worldwide Holdings Inc (HLT) is a lodging company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported HLT revenue for 2024-12-31 was $11.17B. Net income was $1.54B. Revenue was up 9.2% from 2023-12-31 to 2024-12-31. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
HLT currently screens at market cap $75.44B and trailing P/E 50.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the HLT and STRO stock pages for the full models.
Not investment advice.